SCHEMBL23360536

SCHEMBL23360536

O=C(O)N1CC[C@@H](Nc2ccc3ncccc3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
POLB P06746 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
PABPC1 P11940 1/20 0.48
HTR3A P46098 1/20 0.47
SYK P43405 1/20 0.46
FLT3 P36888 1/20 0.46
TRPV1 Q8NER1 1/20 0.45
ALDH1A1 P00352 3/20 0.44
GSK3B P49841 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
BRD4 O60885 1/20 0.44
RAB9A P51151 3/20 0.43
NAMPT P43490 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23360539 1.00 NPC1 (0.50) NPC1POLBKMT2AMEN1MAPT
SCHEMBL23360513 1.00 NPC1 (0.50) NPC1POLBKMT2AMEN1MAPT
SCHEMBL23360655 0.91 CHRNA7 (0.47) KMT2AMEN1HTR3ATRPV1GSK3B
SCHEMBL23360656 0.91 CHRNA7 (0.47) KMT2AMEN1HTR3ATRPV1GSK3B
SCHEMBL23360105 0.91 CHRNA7 (0.47) KMT2AMEN1HTR3ATRPV1GSK3B
SCHEMBL23359921 0.85 KDM4E (0.52) NPC1TRPV1ALDH1A1HSD17B10RAB9A
SCHEMBL23360156 0.85 KDM4E (0.52) NPC1TRPV1ALDH1A1HSD17B10RAB9A
SCHEMBL23359917 0.85 KDM4E (0.52) NPC1TRPV1ALDH1A1HSD17B10RAB9A
SCHEMBL28951986 0.84 ALDH1A1 (0.51) NPC1POLBMAPTTRPV1ALDH1A1
SCHEMBL29862759 0.84 ALDH1A1 (0.51) NPC1POLBMAPTTRPV1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL NPC1 2057/4885POLB 218/4885KMT2A 2822/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL NPC1 2057/4885POLB 218/4885KMT2A 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.